SCHEMBL24448772

SCHEMBL24448772

C=C(CN1CCCCC1)C(=C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 6/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
STAT6 P42226 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPK1 P28482 1/20 0.33
NPC1 O15118 1/20 0.33
EGFR P00533 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
SIGMAR1 Q99720 1/20 0.31
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAOB P27338 1/20 0.31
PSMB1 P20618 1/20 0.31
PSMB5 P28074 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23735867 0.94 SIGMAR1 (0.35) GAAALDH1A1SMN1; SMN2STAT6NPC1
SCHEMBL20314964 0.80 GAA (0.44) GAAMEN1KMT2AALDH1A1HTT
SCHEMBL22278103 0.78 GAA (0.40) GAAMEN1KMT2AALDH1A1HTT
SCHEMBL24448727 0.77 GAA (0.33) GAAMEN1KMT2AALDH1A1HTT
SCHEMBL24448406 0.77 GAA (0.33) GAAMEN1KMT2AALDH1A1HTT
SCHEMBL11269504 0.72 ALDH1A1 (0.53) GAAMEN1KMT2AALDH1A1HTT
SCHEMBL10246527 0.70 ALDH1A1 (0.45) GAAMEN1KMT2AALDH1A1HTT
SCHEMBL10248708 0.70 ALDH1A1 (0.45) GAAMEN1KMT2AALDH1A1HTT
SCHEMBL24331648 0.70 ALDH1A1 (0.50) GAAALDH1A1HTTSMN1; SMN2STAT6
SCHEMBL1708844 0.70 GAA (0.50) GAAMEN1KMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4001269-A1 BENZOISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER Amgen Inc. (US) 2022-05-25 EP disclosed